Showing results (81-90 of 329) with videos related to
Sort By:
Pageof 33
The Journal of Allergy and Clinical Immunology|May 4, 2010
Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitisBruce M Prenner, Bobby Q Lanier, David I Bernstein, et al.Vaccine|November 6, 2010
Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccinationRamu A Subbramanian, Saleem Basha, Mohamed T Shata, et al.Journal of Virological Methods|February 5, 2003
Quantitative-competitive PCR monitoring of viral load following experimental guinea pig cytomegalovirus infectionMark R Schleiss, Nigel Bourne, Fernando J Bravo, et al.The Pediatric Infectious Disease Journal|March 5, 2009
Rotavirus meningoencephalitis in a previously healthy child and a review of the literatureMichelle Dickey, Linda Jamison, Linda Michaud, et al.The Journal of Allergy and Clinical Immunology|January 8, 2011
Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adultsHarold S Nelson, Hendrik Nolte, Peter Creticos, et al.Allergy and Asthma Proceedings|June 25, 2009
Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroidsWilliam E Berger, Edward Kerwin, David I Bernstein, et al.Postgraduate Medicine|March 23, 2017
Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthmaStephen Brunton, Harold S Nelson, David I Bernstein, et al.Sexually Transmitted Diseases|February 22, 2018
Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-ProtectionMónica Saccucci, Eduardo L Franco, Lili Ding, et al.Antiviral Research|February 20, 2010
Recurrent vaginal shedding of herpes simplex type 2 virus in the mouse and effects of antiviral therapyNicholas Farley, David I Bernstein, Fernando J Bravo, et al.Pediatrics|December 15, 2010
Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 dosesLea E Widdice, David I Bernstein, Anthony C Leonard, et al.Pageof 33